Dual-targeting strategies for cancer and diabetes: Converging pharmacological pathways and repurposed therapies
{{output}}
The rising global burden of cancer and diabetes mellitus, particularly type 2 diabetes (T2DM), underscores a critical need for integrated therapeutic strategies. Epidemiological studies reveal a compelling bidirectional association between these diseases, with... ...
